Tacrolimus: all 596 studies that test it
Page 3 of 6. Open to participants first (54), then studies with results posted, then the rest; newest registration first within each.
- A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant PatientsCompletedNCT00282256Phase 2Results posted
- A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant PatientsCompletedNCT00282243Phase 2Results posted
- Hematopoietic Stem Cell Support in VasculitisTerminatedNCT00278512Phase 1Results posted
- Study of ISA247 (Voclosporin) in De Novo Renal TransplantationCompletedNCT00270634Phase 2Results posted
- Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or TacrolimusTerminatedNCT00260208Phase 4Results posted
- A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant RecipientsCompletedNCT00195429Phase 4Results posted
- A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy ImmunosuppressionTerminatedNCT00166712Phase 4Results posted
- Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic RegimensCompletedNCT00157014Phase 3Results posted
- S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed LymphomaTerminatedNCT00121186Phase 2Results posted
- Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver TransplantCompletedNCT00118742Phase 4Results posted
- A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical ProstatectomyCompletedNCT00106392Phase 4Results posted
- Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation PatientsCompletedNCT00105235Phase 2Results posted
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic CancerCompletedNCT00089011Phase 2Results posted
- Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant RecipientsTerminatedNCT00086346Phase 3Results posted
- Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in AdultsCompletedNCT00078559Phase 1/2Results posted
- Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant RecipientsCompletedNCT00064701Phase 3Results posted
- NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/DisordersCompletedNCT00053989Phase 2Results posted
- Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerCompletedNCT00049504Phase 2Results posted
- Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric SarcomasCompletedNCT00043979Phase 2Results posted
- Islet Transplantation for Type 1 DiabetesCompletedNCT00014911Phase 2Results posted
- Tyrosine Vs Tacrolimus With NB-UVB in VitiligoCompletedNCT07532330Not applicable
- Photobiomodulation in Combination With Topical Cyclosporine A or TacrolimusCompletedNCT07239128Early Phase 1
- Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)CompletedNCT06638879Phase 1
- Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness BurnsTerminatedNCT05856994Phase 1
- Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SSStatus unknownNCT05694130Phase 2/3
- Tacrolimus for Thrombocytopenia in SSStatus unknownNCT05678335Phase 2/3
- Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHDActive, not recruitingNCT05621759Phase 2
- A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus HydrocortisoneCompletedNCT05607901Phase 2
- An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant RecipientsTerminatedNCT05501574Phase 2
- Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)CompletedNCT05396898Phase 4
- Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell TransplantsActive, not recruitingNCT05364762Phase 2
- A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy VolunteersStatus unknownNCT05353010Phase 1
- Tacrolimus Versus Hydrocortisone in Atopic DermatitisCompletedNCT05324618Phase 4
- Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD TreatmentCompletedNCT05294666Phase 4
- Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line TherapyStatus unknownNCT05221411Phase 4
- Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult ParticipantsCompletedNCT05202145Phase 1
- A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsCompletedNCT05153915Phase 4
- A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation RecipientsCompletedNCT05152628Phase 4
- Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)Active, not recruitingNCT05148715Phase 2
- A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy AdultsCompletedNCT05109390Phase 1
- NOMINATE/ Minimisation of Immunosuppression in Kidney TransplantationWithdrawnNCT05073822Phase 1/2
- Uses of Tacrolimus in Behcet DiseaseCompletedNCT05032248Not applicable
- ENvarsus for Impaired Glucose Tolerance Post REnal transplAnTWithdrawnNCT04973982Not applicable
- Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and LeukemiaWithdrawnNCT04961801Phase 1/2
- Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in SingaporeCompletedNCT04825262Not applicable
- Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe HemoglobinopathiesWithdrawnNCT04776850Early Phase 1
- Evaluate the Efficacy and Safety of the ADVAGRAF®CompletedNCT04763096Phase 4
- To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant RecipientsCompletedNCT04761731Phase 4
- The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune ThrombocytopeniaStatus unknownNCT04747080Phase 2
- Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant RecipientsActive, not recruitingNCT04720326Phase 4
- Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney TransplantActive, not recruitingNCT04665310Phase 4
- Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT04646356Phase 2
- The Study of Pharmacokinetic Interactions Between HL237 and TacrolimusStatus unknownNCT04633733Phase 1
- The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman SyndromeStatus unknownNCT04590183Not applicable
- Tacrolimus as Treatment of Breast Cancer-Related LymphedemaCompletedNCT04541290Phase 1/2
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
- Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy SubjectsCompletedNCT04498741Phase 1
- PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release TacrolimusCompletedNCT04496401Phase 4
- Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)WithdrawnNCT04415476Phase 2
- Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia PatientsCompletedNCT04403321Phase 2
- Prevention of Breast Cancer-related Lymphedma With TacrolimusStatus unknownNCT04390685Phase 1/2
- Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung InjuryStatus unknownNCT04341038Phase 3
- A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.WithdrawnNCT04263519Phase 2
- Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute LeukemiaActive, not recruitingNCT04262843Phase 2
- Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver TransplantsCompletedNCT04237246Phase 4
- Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity EffectsActive, not recruitingNCT04207177Phase 4
- Autologous Transplant Targeted Against Crohn'sWithdrawnNCT04154735Phase 2
- Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.CompletedNCT04102943Phase 4
- Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic SyndromeCompletedNCT04048161Phase 4
- Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell TransplantationActive, not recruitingNCT04018937Phase 2
- Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical StudyCompletedNCT04009525Phase 4
- Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.WithdrawnNCT03978494Phase 1
- Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal TransplantationCompletedNCT03968588Phase 4
- Tacrolimus Treatment for Refractory Autoimmune CytopeniaStatus unknownNCT03918265Phase 4
- Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren SyndromeCompletedNCT03865888Phase 3
- Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney TransplantsActive, not recruitingNCT03841097Phase 4
- Veloxis de Novo Kidney Transplant ECSWDStatus unknownNCT03828682Phase 4
- Envarsus XL Immunosuppression Following Liver TransplantationCompletedNCT03828058Phase 2
- Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft OutcomeCompletedNCT03794492Phase 4
- Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung DiseaseStatus unknownNCT03770663Phase 3
- Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release TacrolimusCompletedNCT03760263Phase 4
- The Vienna Prograf and Endothelial Progenitor Cell Extension StudyCompletedNCT03751332Phase 4
- A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)CompletedNCT03737708Phase 4
- Tacrolimus for Malar EdemaStatus unknownNCT03715387Phase 2/3
- Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive RegimenActive, not recruitingNCT03672110Phase 3
- Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant RecipientsCompletedNCT03644485Phase 4
- Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease PatientsTerminatedNCT03640026Phase 4
- Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic DermatitisCompletedNCT03614221Phase 2
- CD40-L Blockade for Prevention of Acute Graft-Versus-Host DiseaseCompletedNCT03605927Phase 1
- Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control TrialStatus unknownNCT03603548Not applicable
- Tacrolimus Treatment for Refractory PRCAStatus unknownNCT03540472Phase 4
- A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant PatientsCompletedNCT03465969Phase 4
- OPTImization of the Dose of tacroliMUS by Bayesian PredictionCompletedNCT03465410Phase 4
- A Novel Combined Therapy for Refractory Vernal KeratoconjunctivitisCompletedNCT03464435Phase 4
- Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant RecipientsStatus unknownNCT03438773Phase 1
- To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant RecipientsCompletedNCT03423225Phase 4
- Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.CompletedNCT03410654Early Phase 1
- Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant RecipientsTerminatedNCT03380936Early Phase 1
- Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing RegimenCompletedNCT03373227Phase 2
- Effectivness of Topical Tacrolimus Monotherapy in Patients With VitiligoStatus unknownNCT03358082Phase 1/2